Kristine Taylor - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Kristine Taylor's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Kristine Taylor
Verified
Producer, ABC News (Australia)
Brisbane
Beats
adventure culture, Design, nature malaysia/borneo and australia., food & wine. destination expert on france news issues in france, europe and australia. as a travel writeras a journo, Hotels
I believe in the freedom of speech.
Content
Expert consensus guidelines: Intravenous iron uses, formulations, administration, and management of reactions
By Layla Van Doren, Marlene Steinheiser, Kristen Boykin, Kristine Taylor Verified| Wiley Online Library Verified 1 INTRODUCTION Intravenous (IV) iron has become an essential component for the treatment of iron deficiency (ID) and iron deficiency anemia (IDA). Earlier formulations, no longer in use, were associated with unacceptable toxicity. Newer iron formulations allow for a total dose infusion (TDI) in 15 to 60 min, obviating multiple unnecessary visits for the same clinical benefit without added toxicity.
By Kristine Taylor Verified| ABC News (Australia) Verified One producer, one camera operator and two blind men rushing through Auckland Airport. There was a short window between our flight from Auckland to Samoa and we had to pretty much run to make the tight turnaround. Airports can be overwhelming for the most seasoned travellers. Add in blindness and it's a whole different story. Plus, we were filming the mad dash for an upcoming Australian Story. I had underestimated what would be required.
Expert consensus guidelines: Intravenous iron uses, formulations, administration, and management of reactions
By Layla Van Doren, Marlene Steinheiser, Kristen Boykin, Kristine Taylor Verified| Wiley Online Library Verified 1 INTRODUCTION Intravenous (IV) iron has become an essential component for the treatment of iron deficiency (ID) and iron deficiency anemia (IDA). Earlier formulations, no longer in use, were associated with unacceptable toxicity. Newer iron formulations allow for a total dose infusion (TDI) in 15 to 60 min, obviating multiple unnecessary visits for the same clinical benefit without added toxicity.
Company Info
ABC News (Australia)
Kauhava, South Ostrobothnia, Finland